Eagle Bay Advisors’s IGM Biosciences IGMS Stock Holding History

Eagle Bay Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-99,635	Closed	-$112K	–	118
2025 Q2	$112K	Hold	99,635	–	–	0.09%	109
2025 Q1	$115K	Buy	99,635 +55,000	+123%	+$102K	0.1%	109
2024 Q4	$273K	Hold	44,635	–	–	0.17%	89
2024 Q3	$738K	Hold	44,635	–	–	0.28%	67
2024 Q2	$307K	Hold	44,635	–	–	0.19%	82
2024 Q1	$431K	Hold	44,635	–	–	0.27%	63
2023 Q4	$371K	Hold	44,635	–	–	0.23%	75
2023 Q3	$373K	Hold	44,635	–	–	0.17%	87
2023 Q2	$412K	Buy	44,635 +3,000	+7%	+$33.6K	0.24%	66
2023 Q1	$572K	Hold	41,635	–	–	0.31%	48
2022 Q4	$708K	Hold	41,635	–	–	0.4%	45
2022 Q3	$947K	Hold	41,635	–	–	0.58%	35
2022 Q2	$751K	Buy	41,635 +6,800	+20%	+$121K	0.45%	40
2022 Q1	$931K	Hold	34,835	–	–	0.76%	23
2021 Q4	$1.02M	Sell	34,835 -460	-1%	-$22.9K	0.65%	23
2021 Q3	$2.32M	Buy	35,295 +460	+1%	+$35.2K	1.3%	12
2021 Q2	$2.9M	Buy	+34,835	New	+$2.58M	2.33%	8

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Eagle Bay Advisors's IGMS Position: Q3 2025 in Review

Eagle Bay Advisors sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 99,635 shares — an estimated $112K sold.

Eagle Bay Advisors first reported a position in IGMS in Q2 2021 and held it in 17 quarters. The position peaked at $2.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Eagle Bay Advisors reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Eagle Bay Advisors sold 99,635 IGM Biosciences shares in Q3 2025, an estimated $112K.
Eagle Bay Advisors first reported a position in IGM Biosciences in Q2 2021 and held it in 17 quarters.
Eagle Bay Advisors's IGM Biosciences position peaked at $2.9M in Q2 2021.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Eagle Bay Advisors's 13F filing for Q3 2025, filed 17 Oct 2025.